Testing effectiveness (Phase 2)Study completedNCT00715169
What this trial is testing
Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
Who this might be right for
Atherosclerosis
Millennium Pharmaceuticals, Inc. 108